Ritholtz Wealth Management’s Sanmina SANM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.62M Sell
18,257
-512
-3% -$112K 0.07% 204
2026
Q1
$2.43M Sell
18,769
-1,254
-6% -$184K 0.04% 328
2025
Q4
$3M Buy
20,023
+3,054
+18% +$451K 0.05% 253
2025
Q3
$1.95M Buy
16,969
+5,847
+53% +$657K 0.04% 337
2025
Q2
$1.09M Buy
11,122
+2,179
+24% +$180K 0.02% 433
2025
Q1
$681K Sell
8,943
-4
-0% -$325 0.02% 501
2024
Q4
$677K Sell
8,947
-203
-2% -$15.1K 0.02% 477
2024
Q3
$626K Buy
9,150
+323
+4% +$22.3K 0.02% 500
2024
Q2
$585K Sell
8,827
-188
-2% -$12K 0.02% 473
2024
Q1
$561K Sell
9,015
-459
-5% -$26.7K 0.02% 498
2023
Q4
$487K Sell
9,474
-2,273
-19% -$116K 0.02% 496
2023
Q3
$638K Sell
11,747
-1,559
-12% -$87.7K 0.03% 398
2023
Q2
$802K Sell
13,306
-5,227
-28% -$287K 0.04% 331
2023
Q1
$1.13M Buy
18,533
+1,251
+7% +$74.9K 0.06% 230
2022
Q4
$990K Buy
17,282
+3,479
+25% +$206K 0.06% 234
2022
Q3
$636K Buy
13,803
+7,490
+119% +$349K 0.03% 336
2022
Q2
$257K Buy
+6,313
New +$261K 0.02% 443

Other funds holding SANM

Ritholtz Wealth Management's SANM Position: Q2 2026 in Review

Ritholtz Wealth Management reduced its Sanmina (SANM) stake by 2.7% in Q2 2026, selling an estimated $112K and leaving 18,257 shares worth $4.62M. The position accounts for 0.07% of the portfolio, ranked #204.

Ritholtz Wealth Management first reported a position in SANM in Q2 2022 and has held it in 17 quarters since. 573 funds tracked by Wall St. Rank hold SANM as of Q2 2026.

  • Ritholtz Wealth Management held 18,257 shares of Sanmina worth $4.62M as of Q2 2026.
  • Ritholtz Wealth Management sold 512 Sanmina shares in Q2 2026, an estimated $112K.
  • Sanmina made up 0.07% of Ritholtz Wealth Management's portfolio in Q2 2026, its #204 holding.
  • Ritholtz Wealth Management first reported a position in Sanmina in Q2 2022 and has held it in 17 quarters since.
  • 573 funds tracked by Wall St. Rank held Sanmina as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.